Monoclonal Antibodies in Immunodiagnosis and Immunotherapy This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Development of Monoclonal Antibodies Specific to Either CD300A < sup > R111 < /sup > or CD300A < sup > Q111 < /sup > or Both
In this study, we successfully generated monoclonal antibodies (mAbs) specific to either CD300AR111 or CD300AQ111 or both. These mAbs are useful for the analysis of CD300A genotype by flow cytometry and the development of an antibody drug for the treatment of various diseases.PMID:37902989 | DOI:10.1089/mab.2023.0017 (Source: Monoclonal Antibodies in Immunodiagnosis and Immunotherapy)
Source: Monoclonal Antibodies in Immunodiagnosis and Immunotherapy - October 30, 2023 Category: Microbiology Authors: Hitoshi Koizumi Chigusa Nakahashi-Oda Wenxin Lyu Yumi Yamashita-Kanemaru Keiji Tabuchi Kazuko Shibuya Akira Shibuya Source Type: research

Development and Characterization of a Novel Neuropilin-2 Antibody for Immunohistochemical Staining of Cancer and Sarcoidosis Tissue Samples
Monoclon Antib Immunodiagn Immunother. 2023 Oct;42(5):157-165. doi: 10.1089/mab.2023.0007.ABSTRACTNeuropilin-2 (NRP2) is a cell surface receptor that plays key roles in lymphangiogenesis, but also in pathophysiological conditions such as cancer and inflammation. NRP2 targeting by efzofitimod, a novel immunomodulatory molecule, is currently being tested for the treatment of pulmonary sarcoidosis. To date, no anti-NRP2 antibodies are available for companion diagnostics. Here we describe the development and characterization of a novel NRP2 antibody. Using a variety of research techniques, that is, enzyme-linked immunoassay, W...
Source: Monoclonal Antibodies in Immunodiagnosis and Immunotherapy - October 30, 2023 Category: Microbiology Authors: Sarah F örster Yeeting E Chong David Siefker Yvonne Becker Ruizhi Bao Erik Escobedo Yang Qing Kaitlyn Rauch Luke Burman Christoph Burkart Philipp Kainz Andrea Cubitt Michael Muders Leslie A Nangle Source Type: research

Where Are We with COVID Boosters?
Monoclon Antib Immunodiagn Immunother. 2023 Oct;42(5):151-152. doi: 10.1089/mab.2023.29014.editorial. Epub 2023 Oct 20.NO ABSTRACTPMID:37862051 | DOI:10.1089/mab.2023.29014.editorial (Source: Monoclonal Antibodies in Immunodiagnosis and Immunotherapy)
Source: Monoclonal Antibodies in Immunodiagnosis and Immunotherapy - October 20, 2023 Category: Microbiology Authors: Thomas Kieber-Emmons Source Type: research

Where Are We with COVID Boosters?
Monoclon Antib Immunodiagn Immunother. 2023 Oct 20. doi: 10.1089/mab.2023.29014.editorial. Online ahead of print.NO ABSTRACTPMID:37862051 | DOI:10.1089/mab.2023.29014.editorial (Source: Monoclonal Antibodies in Immunodiagnosis and Immunotherapy)
Source: Monoclonal Antibodies in Immunodiagnosis and Immunotherapy - October 20, 2023 Category: Microbiology Authors: Thomas Kieber-Emmons Source Type: research